Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kari Christine Nadeau, Stanford University
ClinicalTrials.gov Identifier:
NCT01510626
First received: November 29, 2011
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)